Biproducts of complement activation (C3a, C5a) act as potent anaphylatoxins capable of inducing inflammation, chemotaxis, increased vascular permeability, and the extravasation of effector immune cells (macrophages, neutrophils, etc.)to sites of viral infection [13]. The gene discussed is C5; the disease is viral infectious disease.